TBK1 and cancer: TBK1’s high hazard ratio identifies it as a potential therapeutic target (Revach et al., 2020), aligns with recent studies proposing TBK1 inhibitors as potential anti-cancer agents (Miranda et al., 2024; Yang and Liu, 2024).